Patent · US Active

Human antibodies against rabies and uses thereof

US7727532B2 · kind B2 · utility

3Cited by

1References

26Claims

0Family size

Assignees

University of Massachusetts · US
Centers for Disease Control and Prevention · US

Inventors

William D. Thomas · San Jose, US
Donna M. Ambrosino · Brookline, US
Robert Mandell · Moraga, US
Susan Sloan · Newton, US
Gregory Babcock · Marlborough, US
Charles Rupprecht · Lawrenceville, US

Key dates

Filing date	Aug 2, 2007
Grant date	Jun 1, 2010
Priority date	—
Expiry date	Oct 31, 2027

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12N2760/20234
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Human monoclonal antibodies that specifically bind to rabies virus, antigen binding portions thereof, and methods of making and using such antibodies and antigen binding portions thereof for treating rabies virus in a subject, are provided herein.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.